Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments
Paz de la Torre, María Jesús Pérez-Lorenzo, Álvaro Alcázar-Garrido, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 715-715
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Alicja Chrzanowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5840-5840
Open Access | Times Cited: 214
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Rui Sun, Jiajia Xiang, Quan Zhou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114614-114614
Closed Access | Times Cited: 183
Novel Tumor-Targeting Nanoparticles for Cancer Treatment—A Review
Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5253-5253
Open Access | Times Cited: 70
In Vivo Applications of Bioorthogonal Reactions: Chemistry and Targeting Mechanisms
Madonna M. A. Mitry, Francesca Greco, Helen M. I. Osborn
Chemistry - A European Journal (2023) Vol. 29, Iss. 20
Open Access | Times Cited: 47
Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
Pingping Liang, Byron Ballou, Xinyi Lv, et al.
Advanced Materials (2021) Vol. 33, Iss. 15
Closed Access | Times Cited: 99
Anti-angiogenesis in cancer therapeutics: the magic bullet
Ayodipupo Sikiru Oguntade, Faez Al-Amodi, Abdullah Alrumayh, et al.
Journal of the Egyptian National Cancer Institute (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 57
An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy
Dan Nicolae Păduraru, Adelina-Gabriela Niculescu, Alexandra Bolocan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1748-1748
Open Access | Times Cited: 46
Nanomedicine tactics in cancer treatment: Challenge and hope
Mazhar Salim Al Zoubi, Raed M. Al‐Zoubi
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103677-103677
Open Access | Times Cited: 40
Advances of nano drug delivery system for the theranostics of ischemic stroke
Wei Lv, YI-JIAO LIU, Shengnan Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
Dimitrios Ι. Avgoulas, Konstantinos S. Tasioulis, Rigini Papi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1439-1439
Open Access | Times Cited: 28
Genetically engineered cellular nanoparticles for biomedical applications
Nishta Krishnan, Fei-Xing Peng, Animesh Mohapatra, et al.
Biomaterials (2023) Vol. 296, pp. 122065-122065
Open Access | Times Cited: 26
Nanomedicine Advancements: Vanadium Oxide Nanoparticles as a Game-Changer in Antimicrobial and Anticancer Therapies
Adebayo Efunnuga, Adeyemi Efunnuga, Asishana Paul Onivefu, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 3715-3756
Closed Access | Times Cited: 10
Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems
Sivakumar S. Moni, Jobran M. Moshi, Sabine Matou‐Nasri, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 296-296
Open Access | Times Cited: 1
<p>A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes</p>
Meilin Zhang, Ying Du, Shujun Wang, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5495-5503
Open Access | Times Cited: 56
Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
Gaetano Gallo, Giuseppina Vescio, Gilda De Paola, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2295-2295
Open Access | Times Cited: 52
Current Status and Future Prospects of Perinatal Stem Cells
Paz de la Torre, Ana I. Flores
Genes (2020) Vol. 12, Iss. 1, pp. 6-6
Open Access | Times Cited: 50
An Up-to-Date Review of Natural Nanoparticles for Cancer Management
Daniel Ion, Adelina-Gabriela Niculescu, Dan Nicolae Păduraru, et al.
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 18-18
Open Access | Times Cited: 41
Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis
Yi Feng, Zhen Liao, Hanxi Zhang, et al.
Chemical Engineering Journal (2022) Vol. 452, pp. 139506-139506
Closed Access | Times Cited: 30
Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles
Shubham Joshi, Sarah Allabun, Stephen Ojo, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2130-2130
Open Access | Times Cited: 22
Advanced nano drug delivery systems for neuroprotection against ischemic stroke
Chenchen Xie, Jun Liao, Ning Zhang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 109149-109149
Closed Access | Times Cited: 21
Nano‐delivery systems as a promising therapeutic potential for epilepsy: Current status and future perspectives
Ahmad Movahedpour, Rasul Taghvaeefar, Ali A. Asadi‐Pooya, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 11, pp. 3150-3159
Open Access | Times Cited: 18
Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines
Shi Du, Hui Xiong, Cheng Xu, et al.
Biomaterials Science (2019) Vol. 7, Iss. 3, pp. 1147-1160
Closed Access | Times Cited: 52
Potential in vivo delivery routes of postbiotics
Amin Abbasi, Neda Hajipour, Paniz Hasannezhad, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 12, pp. 3345-3369
Closed Access | Times Cited: 45
Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation
David J. Lundy, Helen Nguyễn, Patrick C.H. Hsieh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 34
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery
Л. С. Литвинова, В. В. Шуплецова, О. Г. Хазиахматова, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top